OptiNose (OPTN) Tops Q2 EPS by 13c

OptiNose (NASDAQ: OPTN) reported Q2 EPS of $0.02, $0.13 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $19.45 million versus the consensus estimate of $16.71 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Cosmos Health posts 31% revenue gain in Q2 and H1 2026